Selinexor
KCP-330-024
Phase 3 small_molecule active
Quick answer
Selinexor for Endometrial Cancer is a Phase 3 program (small_molecule) at Karyopharm Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Karyopharm Therapeutics
- Indication
- Endometrial Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active